ACTELION PHARMACEUTICALS LTD v. AUROBINDO PHARMA USA INC. et al > Summary
Court Case Number 3:19-cv-15437
Filing Date Jul 16, 2019
Termination Date Jul 15, 2020
Court New Jersey District Court
Status Judgment - Judgment on Consent
JudgesFreda L. Wolfson, Lois H. Goodman
Plaintiff
Plaintiff Attorneys
6Actelion Pharmaceuticals
Attorney Name: William C. Baton
Saul Ewing LLP
Actelion Pharmaceuticals
Attorney Name: Charles M. Lizza
Saul Ewing LLP
Actelion Pharmaceuticals
Attorney Name: David Leigh Moses
Saul Ewing LLP
Actelion Pharmaceuticals
Attorney Name: Sarah A. Sullivan
Saul Ewing LLP
Actelion Pharmaceuticals
Attorney Name: Bruce M. Wexler
Paul Hastings
Actelion Pharmaceuticals
Attorney Name: Preston K. Ratliff II
Paul Hastings
Defendant Attorneys
4Aurobindo Pharma USA
Attorney Name: Marc D. Youngelson
Cosner Law Group
Aurobindo Pharma USA
Attorney Name: Steven Jerome Moore
Withersworldwide
Aurobindo Pharma
Attorney Name: Marc D. Youngelson
Cosner Law Group
Aurobindo Pharma USA
Attorney Name: James E. Nealon
Withersworldwide
Counter Defendant
4Actelion Pharmaceuticals
Attorney Name: William C. Baton
Saul Ewing LLP
Actelion Pharmaceuticals
Attorney Name: Charles M. Lizza
Saul Ewing LLP
Actelion Pharmaceuticals
Attorney Name: David Leigh Moses
Saul Ewing LLP
Actelion Pharmaceuticals
Attorney Name: Sarah A. Sullivan
Saul Ewing LLP
Counter Claimant
2Aurobindo Pharma
Attorney Name: Marc D. Youngelson
Cosner Law Group
Aurobindo Pharma USA
Attorney Name: Marc D. Youngelson
Cosner Law Group
Cause
15:1126 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 07094781 | Sulfamides and their use as endothelin receptor antagonists | Aug 22, 2006 |
